Sanofi stock is surging with a Golden Cross formation and promising Dupixent results. With FDA review and potential approval, investors are excited.

High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...

The following seven leading European stocks all offer significant scale, along with insulation from U.S. market volatility ...

Dupilumab had a fivefold improvement in sustained disease remission in bullous pemphigoid compared with placebo, along with a significant reduction in oral corticosteroid use.

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

Pharma brands achieved the most impressions from ABC and saw a year-over-year increase in impressions from cable channels like Fox News, CNN and MSNBC.

Novel Modes of Treatment and Drugs Spur the Demand in the Immuno-oncology Market: Fact Report ROCKVILLE, MD, UNITED STATES, March 13, ...

Nasal Polyps Treatment Market Research Report The global nasal polyps treatment market is expected to reach around $4,243.9 million by 2030 ...

This story was originally published . Sign up for their newsletters. By Adam Echelman and Erica Yee, CalMatters $390,000 to ...

European equities traded in the US as American depositary receipts were lower late Wednesday morning, declining 0.21% to 1,391.26 on the S&P Europe Select ADR Index. From continental Europe, the ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12,624.35 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...